登录
注册
首页
个人居家检测
临床应用研究
科研合作项目
合作与服务
社区
纯合片段分析
姓氏祖源
祖源平均脸
基因关系
基因保险助手
原始数据
使用 WeGene 需要启用 Cookies, 请启用后刷新页面获得更好的体验
社区首页
小组
2型糖尿病
2型糖尿病
发起讨论
2型糖尿病
28 个讨论
只看精华帖
按热门排序
按最新排序
2型糖尿病检测貌似准确性有待提高
我们的洗手间
• 最后回复
hayamahasuki
•
2024-09-26 15:19
4262
2
• 来自相关小组
2型糖尿病会很多吗?
亓小三
• 最后回复
WeChat_DA6C6F
•
2024-07-08 21:44
1544
7
• 来自相关小组
2型糖尿病常人的16.42倍,,
阳旬嘉俊
• 最后回复
何真人
•
2020-07-10 01:03
5065
19
• 来自相关小组
据说一个游戏大神因为糖尿病退役了?
咆哮的NTM基因
• 最后回复
an15001864256
•
2020-06-10 12:53
3372
5
• 来自相关小组
我父亲有糖尿病,我只有0.21你们可以参考下我的位点信息
珂学发展观
• 最后回复
天台仙人
•
2019-12-14 12:36
4941
4
• 来自相关小组
吃素能让人远离糖尿病?
佛系的CALCA基因
• 最后回复
佛系的CALCA基因
•
2019-12-02 11:40
3685
5
• 来自相关小组
糖尿病风险高好多东西都不能吃了
范雪波
• 最后回复
何真人
•
2019-08-25 13:49
3032
3
• 来自相关小组
16倍。。我是不是必得了
另类的NAT1基因
• 最后回复
horinee
•
2019-04-10 14:52
3452
2
• 来自相关小组
这些百分比景观规划什么意思?
chenjing28
• 最后回复
horinee
•
2019-04-09 14:01
3594
1
• 来自相关小组
关于血糖、糖尿病相关检测报告结果互相矛盾的疑问
深沉的PKHD1基因
• 最后回复
zutonglee
•
2018-12-28 15:25
4694
6
• 来自相关小组
风险计算算法?30多倍就是肯定会得了吗
干练的1号染色体
• 最后回复
赵日天2
•
2018-11-21 10:34
4393
3
• 来自相关小组
【转】从饮食上预防2型糖尿病
sneer
• 2018-09-16 02:32
3693
0
• 来自相关小组
刚刚更新什么了
点苍渔影
• 最后回复
llllotus
•
2018-08-22 20:37
4313
7
• 来自相关小组
这个的风险可不可以直接当成是肥胖的概率呢 数值越大就代表着越容易肥胖
狂笑的PDE1C基因
• 最后回复
狂笑的PDE1C基因
•
2018-08-20 12:46
3419
1
• 来自相关小组
7.36倍,这个主要还是要少吃多动
sigmarlu
• 最后回复
唱歌的14号染色体
•
2018-08-14 11:15
3271
1
• 来自相关小组
二型糖尿病 10倍
duncangu
• 最后回复
icecream0324
•
2018-08-09 13:48
4611
13
• 来自相关小组
1.55风险大不大
Zenki_Q
• 最后回复
温暖的15号染色体
•
2018-07-30 18:43
3488
2
• 来自相关小组
我概率0.33,但空腹血糖已6.5,有解决办法吗?
英俊的DLG2基因
• 最后回复
conanqdw
•
2018-07-04 08:54
3901
4
• 来自相关小组
关于一个二型糖尿病的报错位点
珂学发展观
• 最后回复
nnlory
•
2018-05-18 20:38
3931
4
• 来自相关小组
二型糖尿病 10倍
duncangu
• 2018-05-18 20:38
3421
0
• 来自相关小组
发起讨论
2型糖尿病
28 个讨论
相关基因
WFS1
位点:RS10012946
NRXN3
位点:RS10146997
TMEM258
位点:RS102275
SUGP1
位点:RS10401969
SDHAF4
位点:RS1048886
RNF6
位点:RS10507349
MTNR1B
位点:RS10830963
GRK5
位点:RS10886471
NOTCH2
位点:RS10923931
CHUK
位点:RS11591741
FTO
位点:RS11642841
位点:RS8050136
位点:RS9939609
ADCY5
位点:RS11708067
SLC16A11
位点:RS117767867
GPSM1
位点:RS11787792
TCF7L2
位点:RS12255372
位点:RS4506565
位点:RS7903146
BCL2
位点:RS12454712
ZMIZ1
位点:RS12571751
SLC30A8
位点:RS13266634
位点:RS3802177
IGF2BP2
位点:RS1470579
位点:RS4402960
RPSAP52
位点:RS1531343
KCNK16
位点:RS1535500
ARAP1
位点:RS1552224
TOMM40
位点:RS157582
ST6GAL1
位点:RS16861329
DGKB
位点:RS17168486
PTPRD
位点:RS17584499
GCK
位点:RS1799884
PPARG
位点:RS1801282
VPS26A
位点:RS1802295
AP3S2
位点:RS2028299
TFAP2B
位点:RS2206277
KCNQ1
位点:RS2237892
位点:RS2237895
位点:RS2237897
TRIB3
位点:RS2295490
MRAS
位点:RS2306374
POC5
位点:RS2307111
KCNQ1OT1
位点:RS231362
CMIP
位点:RS2925979
TEX14
位点:RS302864
POU5F1
位点:RS3130501
LPL
位点:RS328
PROX1-AS1
位点:RS340874
DYRK1B
位点:RS367643250
PEPD
位点:RS3786897
位点:RS10425678
MTTP
位点:RS3816873
SRR
位点:RS391300
ZBED3-AS1
位点:RS4457053
ADAMTS9-AS2
位点:RS4607103
CDKAL1
位点:RS4712523
位点:RS7756992
位点:RS9465871
HNF4A
位点:RS4812829
ANK1
位点:RS516946
KCNJ11
位点:RS5219
MAEA
位点:RS6815464
ARL15
位点:RS702634
GLIS3
位点:RS7041847
HMG20A
位点:RS7178572
PNPLA3
位点:RS738409
RASGRP1
位点:RS7403531
HNF1B
位点:RS757210
位点:RS11651052
CEP68
位点:RS7572857
THADA
位点:RS7578597
RBMS1
位点:RS7593730
GCKR
位点:RS780094
PRC1-AS1
位点:RS8042680
位点:RS2290203
JAZF1
位点:RS864745
TP53INP1
位点:RS896854
ZFAND3
位点:RS9470794
SGCG
位点:RS9552911
MACF1
位点:RS2296172
KIF9
位点:RS2276853
ACSL1
位点:RS60780116
JADE2
位点:RS329122
SSR1
位点:RS9505118
UBE3C
位点:RS1182436
位点:RS1182389
BRAF
位点:RS9648716
PLEKHA1
位点:RS2292626
HSD17B12
位点:RS1061810
WSCD2
位点:RS3764002
ABCB9
位点:RS4275659
FAM234A
位点:RS9940149
BPTF
位点:RS12602912
MLX
位点:RS665268
ZZEF1
位点:RS7224685
GLP2R
位点:RS78761021
ZHX3
位点:RS17265513
PTGFRN
位点:RS1127655
PTH1R
位点:RS11926707
MBNL1
位点:RS4472028
SCD5
位点:RS993380
YTHDC2
位点:RS10077431
CTTNBP2
位点:RS13239186
RELN
位点:RS2299383
ZNF34
位点:RS2294120
USP3
位点:RS982077
EYA2
位点:RS6066138
SAMM50
位点:RS4823182
GRB14
位点:RS75536691
PSMD6
位点:RS3816157
MIR548AC
位点:RS1496653
FSCN3
位点:RS806215
PAX4
位点:RS2233580
ETS1
位点:RS11819995
GP2
位点:RS117267808
NFATC2
位点:RS6021276
Replication of the association between variants in the WFS1 gene and risk of type 2 diabetes in European populations
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Transferability of Type 2 Diabetes Implicated Loci in Multi-Ethnic Cohorts from Southeast Asia
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Association of TCF7L2 Gene Polymorphisms with T2DM in the Population of Hyderabad, India
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Association between SLC30A8 rs13266634 Polymorphism and Type 2 Diabetes Risk: A Meta-Analysis
Replication of Genome-Wide Association Studies of Type 2 Diabetes Susceptibility in Japan - See more at: http://press.endocrine.org/doi/10.1210/jc.2008-0452?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmedsthash.tkccZ0hT.dpuf
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
A polymorphism in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer: findings from a population-based, case-control study (the ProtecT study)
PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus
A Genome-Wide Association Study Identifies Susceptibility Variants for Type 2 Diabetes in Han Chinese
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
The TRIB3 Q84R Polymorphism and Risk of Early-Onset Type 2 Diabetes
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
A form of the metabolic syndrome associated with mutations in DYRK1B.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan
A common functional exon polymorphism in the microsomal triglyceride transfer protein gene is associated with type 2 diabetes, impaired glucose metabolism and insulin levels
A Genome-Wide Association Study Identifies Susceptibility Variants for Type 2 Diabetes in Han Chinese
Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Confirmation of Multiple Risk Loci and Genetic Impacts by a Genome-Wide Association Study of Type 2 Diabetes in the Japanese Population
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Replication of KCNJ11 (p.E23K) and ABCC8 (p.S1369A) Association in Russian Diabetes Mellitus 2 Type Cohort and Meta-Analysis
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Transferability of Type 2 Diabetes Implicated Loci in Multi-Ethnic Cohorts from Southeast Asia
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Replication Study of Candidate Genes Associated With Type 2 Diabetes Based On Genome-Wide Screening
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Transferability of Type 2 Diabetes Implicated Loci in Multi-Ethnic Cohorts from Southeast Asia
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population